Share-based Payment Arrangement, Expense of Celularity Inc from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Celularity Inc quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Celularity Inc Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,041,000, a 24% decline year-over-year.
  • Celularity Inc Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $10,067,000, a 18% decline year-over-year.
  • Celularity Inc annual Share-based Payment Arrangement, Expense for 2024 was $11,569,000, a 23% decline from 2023.
  • Celularity Inc annual Share-based Payment Arrangement, Expense for 2023 was $15,017,000, a 5.3% decline from 2022.
  • Celularity Inc annual Share-based Payment Arrangement, Expense for 2022 was $15,856,000, a 60% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Celularity Inc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,067,000 $2,041,000 -$631,000 -24% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $10,698,000 $2,448,000 -$542,000 -18% 01 Apr 2025 30 Jun 2025 10-Q 29 Aug 2025 2025 Q2
Q1 2025 $11,240,000 $2,637,000 -$329,000 -11% 01 Jan 2025 31 Mar 2025 10-Q 29 Aug 2025 2025 Q1
Q4 2024 $11,569,000 $2,941,000 -$634,000 -18% 01 Oct 2024 31 Dec 2024 10-K 08 May 2025 2024 FY
Q3 2024 $12,203,000 $2,672,000 -$926,000 -26% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $13,129,000 $2,990,000 -$866,000 -22% 01 Apr 2024 30 Jun 2024 10-Q 29 Aug 2025 2025 Q2
Q1 2024 $13,995,000 $2,966,000 -$1,022,000 -26% 01 Jan 2024 31 Mar 2024 10-Q 29 Aug 2025 2025 Q1
Q4 2023 $15,017,000 $3,575,000 -$811,000 -18% 01 Oct 2023 31 Dec 2023 10-K 08 May 2025 2024 FY
Q3 2023 $15,828,000 $3,598,000 -$921,000 -20% 01 Jul 2023 30 Sep 2023 10-Q 06 Dec 2024 2024 Q3
Q2 2023 $16,749,000 $3,856,000 -$673,000 -15% 01 Apr 2023 30 Jun 2023 10-Q 07 Nov 2024 2024 Q2
Q1 2023 $17,422,000 $3,988,000 +$1,566,000 +65% 01 Jan 2023 31 Mar 2023 10-Q 16 Oct 2024 2024 Q1
Q4 2022 $15,856,000 $4,386,000 -$13,706,000 -76% 01 Oct 2022 31 Dec 2022 10-K 30 Jul 2024 2023 FY
Q3 2022 $29,562,000 $4,519,000 -$2,667,000 -37% 01 Jul 2022 30 Sep 2022 10-Q 03 Jan 2024 2023 Q3
Q2 2022 $32,229,000 $4,529,000 -$9,194,000 -67% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $41,423,000 $2,422,000 +$1,413,000 +140% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023 2023 Q1
Q4 2021 $40,010,000 $18,092,000 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $7,186,000 +$6,103,000 +564% 01 Jul 2021 30 Sep 2021 10-K 31 Mar 2023 2022 FY
Q2 2021 $13,723,000 01 Apr 2021 30 Jun 2021 10-K 31 Mar 2023 2022 FY
Q1 2021 $1,009,000 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2020 $1,083,000 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3

Celularity Inc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $11,569,000 -$3,448,000 -23% 01 Jan 2024 31 Dec 2024 10-K 08 May 2025 2024 FY
2023 $15,017,000 -$839,000 -5.3% 01 Jan 2023 31 Dec 2023 10-K 08 May 2025 2024 FY
2022 $15,856,000 -$24,154,000 -60% 01 Jan 2022 31 Dec 2022 10-K 30 Jul 2024 2023 FY
2021 $40,010,000 +$35,639,000 +815% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $4,371,000 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.